Loading stock data…
ALHC
$20.26-2.28 (-10.12%)
Market ClosedLast close May 1
Alignment Healthcare, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Alignment Healthcare, Inc. in the Healthcare sector is trading at $20.26. The stock is currently 15% below its 52-week high of $23.87, remaining 11.5% above its 200-day moving average. Technical signals show neutral RSI of 45 and bearish MACD signal, explaining why ALHC maintains its current momentum and trend strength. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 45) — price action in range
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$20.26
Potential Downside
100%
Whystock Fair Value$0.00
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus13 analysts
Mean target$25.38+25.3%
Range$18.00 – $30.00
Fundamentals
Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States. It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans. Alignment Healthcare, Inc. wa...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$4.26B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.20
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-28.42%
Volume
Today's trading volume
13.84M
Recent News
Alignment Healthcare Inc (ALHC) Q1 2026 Earnings Call Highlights: Strong Growth and Strategic ...
Alignment Healthcare Inc (ALHC) reports robust revenue and membership growth, while addressing operational challenges and raising full-year guidance.
Alignment Healthcare Q1 Earnings Call Highlights
Alignment Healthcare (NASDAQ:ALHC) reported first-quarter 2026 results marked by continued membership growth, margin improvement, and an earnings result that exceeded management’s guidance, as executives highlighted progress in scaling the company’s Medicare Advantage platform and investments in aut
Alignment Healthcare (ALHC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Alignment Healthcare (ALHC) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Alignment Healthcare (ALHC) Q1 Earnings and Revenues Top Estimates
Alignment Healthcare (ALHC) delivered earnings and revenue surprises of +400.00% and +1.56%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Alignment Healthcare (NASDAQ:ALHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops
Health insurance company Alignment Healthcare (NASDAQ:ALHC) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 33.3% year on year to $1.24 billion. On the other hand, next quarter’s revenue guidance of $1.31 billion was less impressive, coming in 0.9% below analysts’ estimates. Its GAAP profit of $0.05 per share was significantly above analysts’ consensus estimates.